Sulfated progesterone metabolites that enhance insulin secretion via TRPM3 are reduced in serum from women with gestational diabetes mellitus

Fan, H.M. et al. (2022) Sulfated progesterone metabolites that enhance insulin secretion via TRPM3 are reduced in serum from women with gestational diabetes mellitus. Diabetes, 71(4), pp. 837-852. (doi: 10.2337/db21-0702) (PMID:35073578) (PMCID:PMC8965673)

Abstract

Serum progesterone sulfates were evaluated in the etiology of gestational diabetes mellitus (GDM). Serum progesterone sulfates were measured using ultra-performance liquid chromatography–tandem mass spectrometry in four patient cohorts: 1) the Hyperglycemia and Adverse Pregnancy Outcomes study; 2) London-based women of mixed ancestry and 3) U.K.-based women of European ancestry with or without GDM; and 4) 11–13 weeks pregnant women with BMI ≤25 or BMI ≥35 kg/m2 with subsequent uncomplicated pregnancies or GDM. Glucose-stimulated insulin secretion (GSIS) was evaluated in response to progesterone sulfates in mouse islets and human islets. Calcium fluorescence was measured in HEK293 cells expressing transient receptor potential cation channel subfamily M member 3 (TRPM3). Computer modeling using Molecular Operating Environment generated three-dimensional structures of TRPM3. Epiallopregnanolone sulfate (PM5S) concentrations were reduced in GDM (P < 0.05), in women with higher fasting plasma glucose (P < 0.010), and in early pregnancy samples from women who subsequently developed GDM with BMI ≥35 kg/m2 (P < 0.05). In islets, 50 µmol/L PM5S increased GSIS by at least twofold (P < 0.001); isosakuranetin (TRPM3 inhibitor) abolished this effect. PM5S increased calcium influx in TRPM3-expressing HEK293 cells. Computer modeling and docking showed identical positioning of PM5S to the natural ligand in TRPM3. PM5S increases GSIS and is reduced in GDM serum. The activation of GSIS by PM5S is mediated by TRPM3 in both mouse and human islets.

• Item Type: Articles
• Additional Information: This research is funded by Tommy’s Charity, the Fetal Medicine Foundation, the Lauren Page Trust, the John Coates Charitable Trust and the National Institute for Health Research (NIHR) Biomedical Research Centres at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London (IS-BRC-1215-20006). C.W. is funded by an NIHR Senior Investigator award.
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: McIlvride, Dr Saraid
• Authors: Fan, H.M., Mitchell, A.L., Bellafante, E., Mcilvride, S., Primicheru, L.I., Giorgi, M., Eberini, I., Syngelaki, A., Sandblom, A.L., Jones, P., McCance, D., Sukumar, N., Periyathambi, N., Weldeselassie, Y., Hunt, K.F., Nicolaides, K.H., Andersson, D., Bevan, S., Seed, P.T., Bewick, G.A., Bowe, J.E., Fraternali, F., Saravanan, P., Marschall, H.-U., and Williamson, C.
• College/School: College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Public Health
• Journal Name: Diabetes
• Publisher: American Diabetes Association
• ISSN: 0012-1797
• ISSN (Online): 1939-327X
• Published Online: 24 January 2022